Cancer Research

Bavarian Nordic- Strengthens Commercial Focus; Pipeline Update

WASHINGTON, September 20 /PRNewswire/-- Bavarian Nordic, the Danish-based biopharmaceutical company, announced it will establish a new separate sales and marketing function to strengthen the company's commercial activities and increase marketing effo ...

Article - Anna Ohlden - Sep 20 2007 - 10:53am

European Committee Issues Positive Opinion On Wyeth's TORISEL(TM) For Advanced Renal Cell Carcinoma

COLLEGEVILLE, Pennsylvania, September 20 /PRNewswire/--- European Committee Issues Negative Opinion on MYLOTARG(R) for Acute Myeloid Leukemia; Wyeth Plans to Appeal Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that it has receiv ...

Article - Anna Ohlden - Sep 20 2007 - 1:26pm

Numerical Model From MIT May Optimize Antibody Drugs

A new study in Nature Biotechnology claims their numerical models and lab experiments have confirmed they can improve a class of drugs based on antibodies by predicting structural changes that will improve its effectiveness. They've already used the m ...

Article - News Staff - Sep 24 2007 - 2:09am

Balancing Sleep: Too Much Increases Risk... So Does Too Little

Researchers have found that lack of sleep can more than double the risk of death from cardiovascular disease. They also found that too much sleep can also more than double the risk of death. One way or another, you are going to die. Strangely, your sleep h ...

Article - News Staff - Sep 24 2007 - 3:13pm

Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau And Dr. David Sidransky To Board Of Directors

LONDON, September 25 /PRNewswire/-- Morria Biopharmaceuticals Plc, a private biopharmaceutical company focusing on first-in-class, novel non-steroidal anti-inflammatory drugs, today announced it has appointed Dr. Johnson Lau and Dr. David Sidransky to its ...

Article - Anna Ohlden - Sep 25 2007 - 8:45am

LAT1 Protein May Be Key To Immune Suppression In Cancer Cells

Researchers say they have found a key biochemical cycle that suppresses the immune response, thereby allowing cancer cells to multiply unabated. The research shows how the biomolecules responsible for healthy T-cells, the body’s first defenders against hos ...

Article - News Staff - Sep 25 2007 - 10:25pm

COX2 Gene Mutation Can Triple Risk Of Ovarian Cancer

Researchers in Portugal have discovered that a specific mutation of the COX2 gene seems to play a role in the onset of ovarian cancer, increasing women’s susceptibility to developing the disease. The discovery raises the possibility that, if the findings a ...

Article - News Staff - Sep 26 2007 - 5:07am

Protherics Licenses Its CoVaccine HT Adjuvant To Nobilon For Influenza Vaccine Indications

BOXMEER, The Netherlands and LONDON, September 26 /PRNewswire/-- Nobilon International B.V., part of Organon, the human health care business unit of Akzo Nobel, and Protherics PLC, the international biopharmaceutical company focused on critical care and c ...

Article - Anna Ohlden - Sep 26 2007 - 2:06am

Alcohol And Cancer: Is Drinking The New Smoking?

Researchers at the Centre for Addiction and Mental Health (CAMH) have clarified the link between alcohol consumption and the risk of head and neck cancers, showing that people who stop drinking can significantly reduce their cancer risk. So enjoy it while ...

Article - News Staff - Sep 26 2007 - 10:41am

Acupuncture Does Not Reduce Radiotherapy-Induced Nausea, But Patients Believe It Does

New research in radiotherapy has found acupuncture does not relieve nausea caused by cancer treatment, despite widespread belief among cancer patients and health care professionals that it does. Maybe that's good enough. The study evaluated the effect ...

Article - News Staff - Sep 26 2007 - 3:15pm